Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparisonMark Ainsworth, Christopher J. Groves, Luke Blackwell et al.|The Lancet Infectious Diseases|2020Cited by 405
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccinesJia Wei, Helen Fryer, Koen B. Pouwels et al.|Nature Medicine|2022Cited by 268
Anti-spike antibody response to natural SARS-CoV-2 infection in the general populationJia Wei, David Bonsall, Philippa C. Matthews et al.|Nature Communications|2021Cited by 147
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19Christos P. Kotanidis, Moustafa Attar, Cheng Xie et al.|The Lancet Digital Health|2022Cited by 41